BP said Ian Tyler will join the board as nonexecutive director and will chair the remuneration committee. Tyler's appointment is effective April 1, and he will help the oil and gas major deliver its ...
Biogen and Eisai said the European Medicines Agency's Committee for Medicinal Products for Human Use has reaffirmed its recommended approval of their Alzheimer's drug Leqembi.